AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy

RecruitingNAAges 6 Years - 12 YearsAllSamsung Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This observational pilot study will include 40 children and adolescents aged 6 to 12 years: 20 with cerebral palsy and 20 with typical development. The main purpose is to determine whether Pupil Labs Neon wearable eye-tracking glasses can be used reliably while participants perform structured tasks using both hands. Each participant will attend one study visit. After assessments of near vision, hand function, visual perception, visual-motor function, and attention-related characteristics, participants will wear the eye-tracking glasses. They will view an instruction card, find target objects, and place the objects into boxes using both hands. The tasks will be completed under three conditions that vary visual-search and sequencing demands, with breaks provided as needed. Researchers will evaluate whether the planned procedures can be completed and whether the recordings provide usable

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria General Inclusion Criteria Children aged 6-12 years * Ability to understand simple instructions required for the study procedures and perform structured visual and bimanual tasks * For children who routinely wear glasses or contact lenses, ability to view near visual stimuli and task materials with their habitual vision correction * Written informed consent provided by a parent or legally authorized representative, with the child providing assent after receiving an age- and developmentally appropriate explanation of the study Cerebral Palsy Group * Diagnosis of cerebral palsy confirmed by a pediatric physiatrist * Manual Ability Classification System (MACS) level I-III * Ability to grasp or manipulate task materials with at least one hand and attempt bimanual task performance Typically Developing Group * Typical developmental history based on parent report and confirmation by the research team * No history of neurological disorders, including cerebral palsy, or musculoskeletal conditions affecting upper-limb function * No diagnosis of a neurodevelopmental disorder that may affect task performance, such as attention-deficit/hyperactivity disorder, autism spectrum disorder, or intellectual disability Exclusion Criteria * Visual impairment that prevents the child from adequately viewing near visual stimuli or task materials, even with habitual vision correction * Severe strabismus, nystagmus, or another ophthalmologic condition judged likely to substantially compromise stable eye-tracking data collection * Severe cognitive, communication, or behavioral difficulties that prevent adequate understanding or performance of the study tasks * Severe upper-limb joint contracture, pain, fracture, or another musculoskeletal condition that prevents safe performance of the bimanual tasks * Uncontrolled epilepsy, acute illness, unstable medical condition, or any other condition judged to make study participation unsafe
๐Ÿ’Š

What it tests

  • Wearable Eye-Tracking Assessment During Structured Bimanual Tasks
๐Ÿ“

Where

1 site
Samsung Medical Center
Seoul, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy